Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Definitive Healthcare Corp. is a healthcare technology company that provides commercial intelligence, data, and analytics solutions to organizations operating across the healthcare, life sciences, and medical technology industries. The company’s core offering is a subscription-based, cloud-enabled platform that aggregates, standardizes, and analyzes healthcare provider, clinical, financial, and market data to support sales, marketing, and strategic decision-making.
The company primarily serves pharmaceutical manufacturers, biotechnology firms, medical device companies, healthcare services providers, and healthcare-related vendors seeking insight into provider behavior, care delivery patterns, and market opportunities. Definitive Healthcare differentiates itself through the breadth of its healthcare data assets, integration of multiple proprietary and licensed datasets, and a focus on actionable intelligence rather than raw data. The company was founded in 2011 and has expanded organically and through acquisitions, culminating in its initial public offering in 2021, which further accelerated investment in data assets and platform capabilities.
Business Operations
Definitive Healthcare operates a single, integrated business model centered on its Healthcare Commercial Intelligence Platform, which generates revenue primarily through recurring subscription fees. Customers access data and analytics tools covering provider demographics, clinical activity, financial performance, affiliations, and patient volume trends, enabling targeted go-to-market strategies. The company’s revenue model is predominantly software-as-a-service, with multi-year subscription contracts representing the majority of sales.
Operations are primarily based in the United States, with data coverage extending to selected international healthcare markets. The company controls proprietary datasets developed through internal research as well as licensed and acquired data assets. Key subsidiaries include Definitive Healthcare, LLC and HIMSS Analytics, Inc., the latter significantly expanding the company’s hospital and health system performance datasets. The company does not rely on manufacturing assets and instead focuses on data engineering, analytics, and customer enablement.
Strategic Position & Investments
Definitive Healthcare’s strategy emphasizes deepening its data moat, expanding platform functionality, and increasing penetration within existing customer segments. Growth initiatives include enhancing predictive analytics, expanding real-world evidence and care utilization insights, and integrating newly acquired datasets into a unified customer experience. The company has also focused on cross-selling capabilities across pharmaceutical, medtech, and healthcare services customers.
A major strategic investment was the acquisition of HIMSS Analytics, which strengthened the company’s position in hospital and health system intelligence and reinforced its role as a comprehensive source of provider and facility-level data. Definitive Healthcare continues to invest in automation, data science, and scalable cloud infrastructure to support long-term growth. Exposure to emerging areas such as value-based care analytics and healthcare market transparency reflects its alignment with broader industry shifts.
Geographic Footprint
Definitive Healthcare is headquartered in North America, with its corporate headquarters located in Framingham, Massachusetts. The majority of its workforce and customers are based in the United States, reflecting the company’s strongest data coverage and commercial presence.
Internationally, the company maintains a more limited but growing footprint, including operations and data coverage in parts of Europe, particularly the United Kingdom. While international revenue represents a smaller portion of total sales, global life sciences customers use the platform to support multinational commercial strategies, giving the company indirect influence across multiple healthcare markets.
Leadership & Governance
Definitive Healthcare was co-founded by Jason Krantz, who has played a central role in shaping the company’s data-driven and customer-centric strategy. Leadership emphasizes disciplined growth, recurring revenue, and long-term investment in proprietary healthcare intelligence assets.
Key executives include:
- Jason Krantz – Chairman and Chief Executive Officer
- Keith Hannon – Chief Financial Officer
- Ryan Jones – Chief Technology Officer
Additional executive leadership roles are disclosed in company filings; however, certain titles and appointments have changed over time. Data inconclusive based on available public sources regarding the full current executive roster and specific leadership responsibilities beyond those listed.